# Blockage Detection Module: ML System Design Documentation

## Overview

This document details the design of the Machine Learning (ML) system for the Blockage Detection Module. It covers the ML pipeline architecture, model training strategy, sensitivity tuning, integration with the parent Visualization Interface, requirement fulfillment, risk mitigation, validation approach, and regulatory compliance.

---

## 1. ML Pipeline Architecture

The Blockage Detection Module employs a structured ML pipeline consisting of three main stages:

### 1.1 Preprocessing
- Input images are normalized to standard resolution and intensity ranges.
- Data augmentation techniques (rotation, flipping, scaling) are applied during training for robustness.
- Anatomical region-of-interest (ROI) extraction isolates vascular structures to reduce noise.
- Image enhancement algorithms improve contrast for subtle lesion visibility.

### 1.2 Inference
- The core ML model is a convolutional neural network (CNN) optimized for lesion detection and classification.
- Input processed images undergo feature extraction to identify potential blockages.
- The model outputs lesion probability heatmaps and bounding box coordinates.

### 1.3 Postprocessing
- Non-maximum suppression (NMS) refines bounding boxes by eliminating redundant detections.
- Lesion candidates are scored and filtered based on model confidence thresholds.
- Final annotations are formatted for direct rendering in the Visualization Interface.

---

## 2. Model Training Approach and Datasets

### 2.1 Training Methodology
- Supervised training with annotated datasets using cross-entropy loss and focal loss to address class imbalance.
- Transfer learning from pretrained medical imaging models accelerates convergence.
- Early stopping and learning rate scheduling applied for optimized training.

### 2.2 Datasets Used
- Internal proprietary dataset of vascular imaging studies with expert-labeled lesions.
- Publicly available vascular lesion image datasets, curated to match project requirements.
- Dataset augmentation ensures coverage of diverse patient demographics and imaging conditions.

---

## 3. Sensitivity Tuning Methodology

- Sensitivity thresholds are calibrated by adjusting classification confidence scores to maximize detection rate while controlling false positives.
- Receiver Operating Characteristic (ROC) curve analysis guides the selection of optimal thresholds.
- Iterative feedback from domain experts refines threshold values for operational deployment.
- Dynamic sensitivity adjustment options allow end-users to balance detection sensitivity with specificity based on clinical use cases.

---

## 4. Integration with Parent Visualization Interface (ID: KXREC5Y1CC4NYQ28M1VNYPAC35SD85Z)

- The module outputs standardized data packages compatible with the Visualization Interface API.
- Real-time streaming of lesion detections supports interactive visualization and user feedback.
- Annotations include metadata (confidence score, lesion size, location) for enhanced user interpretation.
- Bidirectional communication enables user corrections to be fed back to the ML model for continuous improvement.

---

## 5. Fulfillment of Key Requirements

- **Requirement KXREC6PEB45DQVN8N8T7JWY770HBFF8:** Ensures comprehensive lesion detection coverage across supported imaging modalities.
- **Requirement KXREC50ZS9YFJP789V9G2FPYTMT1KJK:** Guarantees seamless integration and synchronized updates within the Visualization Interface framework.

---

## 6. Risk Mitigation for Inaccurate Lesion Detection (ID: KXREC436JFWJQQB9SSBEAZ77VDMBG6Q)

- Multi-stage verification combining ML confidence with heuristic postprocessing reduces false positives.
- User override mechanisms allow clinicians to validate or dismiss detected lesions.
- Continuous monitoring of model performance with anomaly detection flags potential accuracy drifts.
- Periodic retraining with new labeled data corrects identified detection errors.

---

## 7. Validation Strategy via Accuracy Test (ID: KXREC7163AZG6KZ897T60Y91765EAXT)

- Quantitative evaluation using hold-out test sets with ground truth annotations.
- Metrics include sensitivity, specificity, precision, recall, F1-score, and area under ROC curve (AUC).
- Cross-validation and external validation datasets ensure generalizability.
- Validation results are reviewed and approved by clinical partners prior to deployment.

---

## 8. Compliance with AI/ML Medical Device Regulations

- The module adheres to relevant regulatory frameworks, including FDA guidance on AI/ML-based Software as a Medical Device (SaMD).
- Data privacy and security practices comply with HIPAA and GDPR requirements.
- Transparent model documentation and traceability facilitate regulatory submissions.
- Post-market monitoring plans include adverse event reporting and periodic software updates.

---

**Version:** 1.0  
**Last Updated:** 2024-06  
**Authors:** ML Engineering Team